world

Game-changing research from the UK… Here’s the group least affected by the corona

According to research conducted in the UK, 2 doses of coronavirus vaccine and Covid-19 infection in the past provide 90 percent protection for at least one year.

The Coronavirus (Covid-19), which was first seen in China in the last days of2019and spread from there around the world, has cost millions of lives.

With the outbreak, the scientific world devoted most of its time to defeating the virus. Thanks to these studies, we are able to understand the virus better every day and take more and more measures against it.

There has been much talk from the UKrecently about the virus, whose variant has been on the agenda with Omicron.

The UK Health Safety Agency concluded that having two doses of the vaccine in addition to the previous infection significantly reduced both symptomatic and asymptomatic cases.

The study found that it provided 90 percent protection from the virus over a year, the Daily Mail reported.

research on 35,000 health workers found that cases of unvaccinated covid improved 85 percent protection after three to nine months, but dropped to 73 percent 15 months after infection.

In people who contracted the coronavirus and had two doses of the vaccine, the rate was 91 percent. After 15 months, the rate dropped to 90 percent.

Game-changing research from the UK... Here's the group least affected by the corona

ISRAEL ANNOUNCES FIRST RESULTS

On the other hand, the first data came in for the fourth dose from Israel. The team also warned that there was an increase in the rate of antibodies after the fourth dose of the Pfizer/BioNTech or Moderna Coronavirus vaccine.

Dr. Gili Regev-Yochay, director of infection at Sheba Medical Center, commented on the study:

‘We’ve been looking at the Pfizer vaccine for two weeks and the Moderna vaccine for a week. And what we’re seeing is that the Pfizer vaccine is causing an increase in the number of antibodies after two weeks. That’s a pretty good increase. Still, that’s probably not enough for Omicron.’

The virtual press conference underlined that these results are preliminary findings and that final results will be announced in the coming weeks.

Related Articles

Back to top button